Skip to main content
. 2022 May 13;17(3):454–460. doi: 10.1016/j.jtumed.2022.04.012

Table 1.

Demographic and clinical characteristics of the study groups on day 1.

Variables Melatonin group
Day 1
Control group
Day 1
P-value
Day 1
Age (years) 61.27 ± 18.09 65.35 ± 19.30 0.376
Sex (male) 19 (57.6) 24 (70.6) 0.316
BMI ([kg/cm]2) 26.66 + 5.32 25.52 + 4.71 0.46
WBC (×1000/μL) 11.41 ± 4.24 12.66 ± 4.37 0.241
Neutrophil (×1000/μL) 9630 ± 3810 11,010 ± 4170 0.199
Lymph (×1000/μL) 880 ± 530 1050 ± 420 0.173
Neutrophil/lymph 14.18 ± 7.10 11.91 ± 5.73 0.190
Platelet (×1000/μL) 221.36 ± 123.03 208.88 ± 87.94
Urea (mg/dL) 70.94 ± 43.99 50.12 ± 23.30 0.019
Cr (mg/dL) 1.25 ± 0.54 1.14 ± 0.46 0.401
ALT (U/L) 65.03 ± 60.75 62.20 ± 67.21 0.871
AST (U/L) 58.21 ± 35.48 56.37 ± 50.44 0.871
CRP (mg/L) 62.73 ± 67.04 64.55 ± 55.15 0.913
ESR (mm/h) 47.66 ± 27.59 55.40 ± 38.80 0.507
APACHE score 19.6 ± 3.35 18.9 ± 4.43 0.682
GCS 7.62 ± 3.95 7.93 ± 3.19 0.721

BMI: Body mass index, WBC: white blood cells, Lymph: lymphocytes, Cr: serum creatinine, ALT: alanine aminotransferase, AST: aspartate aminotransferase, CRP: C-reactive protein, ESR: erythrocyte sedimentation rate, APACHE: Acute Physiology and Chronic Health Evaluation, GCS: Glasgow Coma Scale.